Istituto Biochimico Italiano Giovanni Lorenzini SpA
FDA Approved Drugs

Istituto Biochimico Italiano Giovanni Lorenzini SpA

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX Discontinued

Total Records 27
Latest Approval Date Dec 20, 2013
Data Source FDA
First Approval Date May 12, 1987

All

View

Discontinued

View

Company Overview

Company

Istituto Biochimico Italiano Giovanni Lorenzini SpA

Country

Italy

Website

Visit Website

info@ibi-lorenzini.com

Social Profiles

Company Snapshot

Istituto Biochimico Italiano Giovanni Lorenzini SpA

Istituto Biochimico Italiano Giovanni Lorenzini S.p.a. Via Fossignano 2, 04011 Aprilia(LT) , Italy

Italy

www.ibi-lorenzini.it/it info@ibi-lorenzini.com View on Map

FDA Approved Drug Records ( 27 records )

2005

29 Nov

RX Application: 65222

Drug Name

AMPICILLIN AND SULBACTAM

Product Number

Dosage Form

Strength

EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL

Approval Date

2005-11-29

65222 / 1 View Details

Active Ingredient

AMPICILLIN SODIUM; SULBACTAM SODIUM

Application Number

65222

Product Number

Dosage Form

Strength

EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL

Approval Date

2005-11-29

Regulatory Status

2005

29 Nov

RX Application: 65222

Drug Name

AMPICILLIN AND SULBACTAM

Product Number

Dosage Form

Strength

EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL

Approval Date

2005-11-29

65222 / 2 View Details

Active Ingredient

AMPICILLIN SODIUM; SULBACTAM SODIUM

Application Number

65222

Product Number

Dosage Form

Strength

EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL

Approval Date

2005-11-29

Regulatory Status

2006

27 Nov

RX Application: 65314

Drug Name

AMPICILLIN AND SULBACTAM

Product Number

Dosage Form

Strength

EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL

Approval Date

2006-11-27

65314 / 1 View Details

Active Ingredient

AMPICILLIN SODIUM; SULBACTAM SODIUM

Application Number

65314

Product Number

Dosage Form

Strength

EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL

Approval Date

2006-11-27

Regulatory Status

1987

12 May

RX Application: 62719

Drug Name

AMPICILLIN SODIUM

Product Number

Dosage Form

Strength

EQ 250MG BASE/VIAL

Approval Date

1987-05-12

62719 / 1 View Details

Active Ingredient

AMPICILLIN SODIUM

Application Number

62719

Product Number

Dosage Form

Strength

EQ 250MG BASE/VIAL

Approval Date

1987-05-12

Regulatory Status

1987

12 May

RX Application: 62719

Drug Name

AMPICILLIN SODIUM

Product Number

Dosage Form

Strength

EQ 1GM BASE/VIAL

Approval Date

1987-05-12

62719 / 2 View Details

Active Ingredient

AMPICILLIN SODIUM

Application Number

62719

Product Number

Dosage Form

Strength

EQ 1GM BASE/VIAL

Approval Date

1987-05-12

Regulatory Status

1987

12 May

RX Application: 62719

Drug Name

AMPICILLIN SODIUM

Product Number

Dosage Form

Strength

EQ 500MG BASE/VIAL

Approval Date

1987-05-12

62719 / 3 View Details

Active Ingredient

AMPICILLIN SODIUM

Application Number

62719

Product Number

Dosage Form

Strength

EQ 500MG BASE/VIAL

Approval Date

1987-05-12

Regulatory Status

1993

12 Jul

Discontinued Application: 62797

Drug Name

AMPICILLIN SODIUM

Product Number

Dosage Form

Strength

EQ 125MG BASE/VIAL

Approval Date

1993-07-12

62797 / 1 View Details

Active Ingredient

AMPICILLIN SODIUM

Application Number

62797

Product Number

Dosage Form

Strength

EQ 125MG BASE/VIAL

Approval Date

1993-07-12

Regulatory Status

Discontinued

1993

12 Jul

RX Application: 62797

Drug Name

AMPICILLIN SODIUM

Product Number

Dosage Form

Strength

EQ 2GM BASE/VIAL

Approval Date

1993-07-12

62797 / 2 View Details

Active Ingredient

AMPICILLIN SODIUM

Application Number

62797

Product Number

Dosage Form

Strength

EQ 2GM BASE/VIAL

Approval Date

1993-07-12

Regulatory Status

2013

20 Dec

RX Application: 201404

Drug Name

AMPICILLIN SODIUM

Product Number

Dosage Form

Strength

EQ 10GM BASE/VIAL

Approval Date

2013-12-20

201404 / 1 View Details

Active Ingredient

AMPICILLIN SODIUM

Application Number

201404

Product Number

Dosage Form

Strength

EQ 10GM BASE/VIAL

Approval Date

2013-12-20

Regulatory Status

2011

30 Jun

RX Application: 90002

Drug Name

NAFCILLIN SODIUM

Product Number

Dosage Form

Strength

EQ 1GM BASE/VIAL

Approval Date

2011-06-30

90002 / 1 View Details

Active Ingredient

NAFCILLIN SODIUM

Application Number

90002

Product Number

Dosage Form

Strength

EQ 1GM BASE/VIAL

Approval Date

2011-06-30

Regulatory Status

2011

30 Jun

RX Application: 90002

Drug Name

NAFCILLIN SODIUM

Product Number

Dosage Form

Strength

EQ 2GM BASE/VIAL

Approval Date

2011-06-30

90002 / 2 View Details

Active Ingredient

NAFCILLIN SODIUM

Application Number

90002

Product Number

Dosage Form

Strength

EQ 2GM BASE/VIAL

Approval Date

2011-06-30

Regulatory Status

2011

20 Apr

RX Application: 90005

Drug Name

NAFCILLIN SODIUM

Product Number

Dosage Form

Strength

EQ 10GM BASE/VIAL

Approval Date

2011-04-20

90005 / 1 View Details

Active Ingredient

NAFCILLIN SODIUM

Application Number

90005

Product Number

Dosage Form

Strength

EQ 10GM BASE/VIAL

Approval Date

2011-04-20

Regulatory Status

1995

11 Dec

Discontinued Application: 62798

Drug Name

OXACILLIN SODIUM

Product Number

Dosage Form

Strength

EQ 1GM BASE/VIAL

Approval Date

1995-12-11

62798 / 1 View Details

Active Ingredient

OXACILLIN SODIUM

Application Number

62798

Product Number

Dosage Form

Strength

EQ 1GM BASE/VIAL

Approval Date

1995-12-11

Regulatory Status

Discontinued

1995

11 Dec

Discontinued Application: 62798

Drug Name

OXACILLIN SODIUM

Product Number

Dosage Form

Strength

EQ 2GM BASE/VIAL

Approval Date

1995-12-11

62798 / 2 View Details

Active Ingredient

OXACILLIN SODIUM

Application Number

62798

Product Number

Dosage Form

Strength

EQ 2GM BASE/VIAL

Approval Date

1995-12-11

Regulatory Status

Discontinued

1995

11 Dec

Discontinued Application: 62798

Drug Name

OXACILLIN SODIUM

Product Number

Dosage Form

Strength

EQ 125MG BASE/VIAL

Approval Date

1995-12-11

62798 / 3 View Details

Active Ingredient

OXACILLIN SODIUM

Application Number

62798

Product Number

Dosage Form

Strength

EQ 125MG BASE/VIAL

Approval Date

1995-12-11

Regulatory Status

Discontinued

1995

11 Dec

Discontinued Application: 62798

Drug Name

OXACILLIN SODIUM

Product Number

Dosage Form

Strength

EQ 250MG BASE/VIAL

Approval Date

1995-12-11

62798 / 4 View Details

Active Ingredient

OXACILLIN SODIUM

Application Number

62798

Product Number

Dosage Form

Strength

EQ 250MG BASE/VIAL

Approval Date

1995-12-11

Regulatory Status

Discontinued

1995

11 Dec

Discontinued Application: 62798

Drug Name

OXACILLIN SODIUM

Product Number

Dosage Form

Strength

EQ 500MG BASE/VIAL

Approval Date

1995-12-11

62798 / 5 View Details

Active Ingredient

OXACILLIN SODIUM

Application Number

62798

Product Number

Dosage Form

Strength

EQ 500MG BASE/VIAL

Approval Date

1995-12-11

Regulatory Status

Discontinued

2009

18 Aug

RX Application: 65448

Drug Name

PENICILLIN G POTASSIUM

Product Number

Dosage Form

Strength

5,000,000 UNITS/VIAL

Approval Date

2009-08-18

65448 / 1 View Details

Active Ingredient

PENICILLIN G POTASSIUM

Application Number

65448

Product Number

Dosage Form

Strength

5,000,000 UNITS/VIAL

Approval Date

2009-08-18

Regulatory Status

2009

18 Aug

RX Application: 65448

Drug Name

PENICILLIN G POTASSIUM

Product Number

Dosage Form

Strength

20,000,000 UNITS/VIAL

Approval Date

2009-08-18

65448 / 2 View Details

Active Ingredient

PENICILLIN G POTASSIUM

Application Number

65448

Product Number

Dosage Form

Strength

20,000,000 UNITS/VIAL

Approval Date

2009-08-18

Regulatory Status

2003

14 Nov

RX Application: 65114

Drug Name

PIPERACILLIN

Product Number

Dosage Form

Strength

EQ 2GM BASE/VIAL

Approval Date

2003-11-14

65114 / 1 View Details

Active Ingredient

PIPERACILLIN SODIUM

Application Number

65114

Product Number

Dosage Form

Strength

EQ 2GM BASE/VIAL

Approval Date

2003-11-14

Regulatory Status

2003

14 Nov

RX Application: 65114

Drug Name

PIPERACILLIN

Product Number

Dosage Form

Strength

EQ 3GM BASE/VIAL

Approval Date

2003-11-14

65114 / 2 View Details

Active Ingredient

PIPERACILLIN SODIUM

Application Number

65114

Product Number

Dosage Form

Strength

EQ 3GM BASE/VIAL

Approval Date

2003-11-14

Regulatory Status

2003

14 Nov

RX Application: 65114

Drug Name

PIPERACILLIN

Product Number

Dosage Form

Strength

EQ 4GM BASE/VIAL

Approval Date

2003-11-14

65114 / 3 View Details

Active Ingredient

PIPERACILLIN SODIUM

Application Number

65114

Product Number

Dosage Form

Strength

EQ 4GM BASE/VIAL

Approval Date

2003-11-14

Regulatory Status

2004

12 Jul

RX Application: 65157

Drug Name

PIPERACILLIN

Product Number

Dosage Form

Strength

EQ 40GM BASE/VIAL

Approval Date

2004-07-12

65157 / 1 View Details

Active Ingredient

PIPERACILLIN SODIUM

Application Number

65157

Product Number

Dosage Form

Strength

EQ 40GM BASE/VIAL

Approval Date

2004-07-12

Regulatory Status

2011

31 May

RX Application: 65523

Drug Name

PIPERACILLIN AND TAZOBACTAM

Product Number

Dosage Form

Strength

EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL

Approval Date

2011-05-31

65523 / 1 View Details

Active Ingredient

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Application Number

65523

Product Number

Dosage Form

Strength

EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL

Approval Date

2011-05-31

Regulatory Status

2011

31 May

RX Application: 65523

Drug Name

PIPERACILLIN AND TAZOBACTAM

Product Number

Dosage Form

Strength

EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL

Approval Date

2011-05-31

65523 / 2 View Details

Active Ingredient

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Application Number

65523

Product Number

Dosage Form

Strength

EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL

Approval Date

2011-05-31

Regulatory Status

2011

31 May

RX Application: 65523

Drug Name

PIPERACILLIN AND TAZOBACTAM

Product Number

Dosage Form

Strength

EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL

Approval Date

2011-05-31

65523 / 3 View Details

Active Ingredient

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Application Number

65523

Product Number

Dosage Form

Strength

EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL

Approval Date

2011-05-31

Regulatory Status

2011

31 May

RX Application: 90498

Drug Name

PIPERACILLIN AND TAZOBACTAM

Product Number

Dosage Form

Strength

EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL

Approval Date

2011-05-31

90498 / 1 View Details

Active Ingredient

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Application Number

90498

Product Number

Dosage Form

Strength

EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL

Approval Date

2011-05-31

Regulatory Status

Related Databases

FDA Inspections
0 View
EDQM CEP
7 View
KDMF
0 View
Japan DMF
0 View
Eudra GMP
0 View
NDC Database
0 View
FDA Approved Drugs Database
27 View
Drug Prices in Switzerland
0 View

Drug Status Breakdown

27 total

RX
Discontinued

Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book

FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

AMPICILLIN AND SULBACTAM

Application Number

65222

Product Number

Active Ingredient

AMPICILLIN SODIUM; SULBACTAM SODIUM

Dosage Form

Strength

EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Required Quantity *

Please enter quantity.

Measurement Unit *

Please select a unit.

Quality Standard *

Please select quality standard.

Request Type *

Please select request type.

Product Specifications *

Please provide product specifications.

Additional Details *

Please enter additional details.

Shipping Preference *

Please select shipping preference.

Expected Delivery Date

Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.